Article: Topical morphine for analgesia in patients with skin grafts.(CLINICAL TRIAL REVIEW)

Article: Phase III randomized study of oral acyclovir in ...
Journal of Drugs in Dermatology;  November 1, 2004 ;     700+ words ... ... safety of this regimen in these patients. Condition Treatment or Intervention Phase Herpes Simplex Drug: acyclovir Phase III Study ID Numbers: 199/15325; UAB-CASG-103 ClinicalTrials.gov Identifier: NCT00006132

Article: Phase III randomized study of oral acyclovir in ...
Journal of Drugs in Dermatology;  October 1, 2003 ;     700+ words ... ... safety of this regimen in these patients. Condition Treatment or Intervention Phase Herpes Simplex Drug: acyclovir Phase III Study ID Numbers: 199/15334; UAB-CASG-104 NLM Identifier: NCT00006135

Article: PHASE III randomized study of oral acyclovir in ...
Journal of Drugs in Dermatology;  October 1, 2003 ;     700+ words ... ... safety of this regimen in these patients. Condition Treatment or Intervention Phase Herpes Simplex Drug: acyclovir Phase III Study ID Numbers: 199/15325; UAB-CASG-103 NLM Identifier: NCT00006132

Article: Clinical trial review.
Journal of Drugs in Dermatology;  December 1, 2003 ;     700+ words ... ... Ulcer Wound Infections Study ID Numbers: 16424-202a ... Procedure: Phototherapy Study ID Numbers: CDR0000065494 ... Identifier: NCT00002975 PHASE III RANDOMIZED STUDY OF ORAL ... Simplex Drug: Acyclovir Phase III Study ID Numbers: 199/15334 ...

Article: Study ID's how our eyes adjust to darkness.
UPI Energy Resources;  October 14, 2009 ;     484 words ...U.S. scientists say they have identified the intricate process that allows a human's eyes to adapt to darkness or bright light very quickly. Vision researchers at Washington University School of Medicine in St. Louis said their discovery could contribute to a better understanding of human diseases

Article: Study ID's fetal growth restriction cause.
UPI Energy Resources;  September 17, 2009 ;     510 words ...Canadian scientists say they've discovered a specific protein plays a critical role in regulating intrauterine growth and lung maturation. University of Montreal researchers, led by Professor Sylvain Meloche, say their findings show the loss of protein kinase Erk3 in mice leads to fetal growth

Article: Study: ID-related infant hospitalizations at ...
Pediatric News;  May 1, 2008 ;     700+ words ...Infectious disease hospitalizations accounted for 43% of all infant hospitalizations in the United States in 2003, at a cost of $690 million, results from a large national analysis of hospital records demonstrated. Younger infants, boys, and nonwhite infants were at increased risk for infectious